胃动素与功能性消化不良研究进展(3)
13 Andriulli A,Grossi E,Buscema M,et al.Artificial neural networks can classify uninvestigated patients with dyspepsia.Eur J Gastroenterol Hepatol,2007,19(12):1055-1058.
14 Van den Elzen BD,Bennink RJ,Holman R,et al.Impaired drinking capacity in patients with functional dyspepsia:intragastric distribution and distal stomach volum.Neurogastroenterol Motil,2007,19(12):968-976.
15 Galligan JJ,Vanner S.Basic and clinical pharmacology of new motility promoting agents.Neurogastroenterol Motil,2005,17(5):643-653.
16 Jonsson BH,Hellstrom PM.Motilin and neuropeptide Y-like immunoreactivity in a psychophysiological stress experiment on patients with functional dyspepsia.Integr Physiol Behav Sci,2000,35(4):256-265.
17 Onoma M,Yogo K,Ozaki K,et al.Oral mitemcinal(gm-611),an erythromycin-derived prokinetic,accelerates normal and experimentally delayed gastric emptying in conscious dogs.Clin Exp Pharmacol Physiol，2008,35(1):35-42.
18 Ozaki K,Yogo K,Sudo H,et al.Effects of mitemcinal(GM-611),an acid-resistant nonpeptide motilin receptor agonist on the gastrointestinal contractile activity in conscious dogs.Pharmacology,2007,79(4):223-235.
19 Katagiri F,Shiga T,Inoue S,et al.Effects of itopride hydrochloride on plasma gut-regulatory peptide and stress-related hormone levels in healthy human subjects.Pharmacology,2006,77(3):115-121.
20 Kamerling IM,Van Haarst AD,Burggraaf J,et al.Motilin effects on the proximal stomach in patients with functional dyspepsia and healthy volunteers.Am J Physiol Gastrointest Liver Physiol，2003,284(5):776-781., 百拇医药(陈 鹏 王春松 孔令斌)
14 Van den Elzen BD,Bennink RJ,Holman R,et al.Impaired drinking capacity in patients with functional dyspepsia:intragastric distribution and distal stomach volum.Neurogastroenterol Motil,2007,19(12):968-976.
15 Galligan JJ,Vanner S.Basic and clinical pharmacology of new motility promoting agents.Neurogastroenterol Motil,2005,17(5):643-653.
16 Jonsson BH,Hellstrom PM.Motilin and neuropeptide Y-like immunoreactivity in a psychophysiological stress experiment on patients with functional dyspepsia.Integr Physiol Behav Sci,2000,35(4):256-265.
17 Onoma M,Yogo K,Ozaki K,et al.Oral mitemcinal(gm-611),an erythromycin-derived prokinetic,accelerates normal and experimentally delayed gastric emptying in conscious dogs.Clin Exp Pharmacol Physiol，2008,35(1):35-42.
18 Ozaki K,Yogo K,Sudo H,et al.Effects of mitemcinal(GM-611),an acid-resistant nonpeptide motilin receptor agonist on the gastrointestinal contractile activity in conscious dogs.Pharmacology,2007,79(4):223-235.
19 Katagiri F,Shiga T,Inoue S,et al.Effects of itopride hydrochloride on plasma gut-regulatory peptide and stress-related hormone levels in healthy human subjects.Pharmacology,2006,77(3):115-121.
20 Kamerling IM,Van Haarst AD,Burggraaf J,et al.Motilin effects on the proximal stomach in patients with functional dyspepsia and healthy volunteers.Am J Physiol Gastrointest Liver Physiol，2003,284(5):776-781., 百拇医药(陈 鹏 王春松 孔令斌)